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Introduction: Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and 
the third most common cause of cancer-related death worldwide. Melissa officinalis L. 
(M. officinalis L.), known as lemon balm is a medicinal plant, which has a wide range of 
pharmacological properties. This study was aimed to assess the chemopreventive effect 
of aqueous extract of M. officinalis (AMO) against diethyl nitrosamine (DEN)-induced 
hepatocellular carcinoma (HCC) in rats. 
Methods and Results: The model of hepatocellular carcinoma was induced by a single 
intraperitoneal injection of DEN (200 mg/kg) as an initiator and after two weeks was 
followed by daily oral administration of 2-acetylaminofluorene (30 mg/kg) as a promoter 
for two weeks. Lemon balm-treated rats were pretreated with AMO intragastrically at 
three different doses two weeks prior to DEN injection. At the end of the experiment, the 
marked reduction of serum biomarkers of liver damage and cancer, including alfa-
fetoprotein (AFP), gamma glutamyl transpeptidase (GGT), alanine transaminase (ALT), 
and aspartate transaminase (AST) were observed in AMO complemented rats  compared 
to DEN-treated animals. Furthermore, the extract exhibited in vivo antioxidant activity by 
elevating GSH concentration and preventing lipid peroxidation in the liver tissues of 
HCC rats. The relative weight of liver was also reduced in lemon balm-treated rats as a 
prognostic marker in HCC. 
Conclusion: Our findings demonstrated that M. officinalis has a chemopreventive effect 
against HCC in rats and can be suggested as a potential agent for the prevention of 
primary liver cancer. 
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Hepatocellular carcinoma (HCC) or primary liver cancer 
is an aggressive tumor that frequently occurs following 
liver inflammation and cirrhosis [‎1, ‎2]. It has been 
extensively reported that viral infections [hepatitis B 
virus (HBV) or hepatitis C virus (HCV)], diabetes,  
non-alcoholic steatohepatitis (NASH) along with some 
genetic diseases such as Wilson’s disease and 
hemochromatosis are the most common causes of this 
deadly cancer. Industrial chemicals, environmental 
pollutants, tobacco smoking, food additives, and 
aflatoxin-B1 are other risk factors that cause 
hepatocarcinogenesis [‎2-5].  
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Diethyl nitrosamine (DEN) or N-Nitrosodiethylamine is 
a representative environmental carcinogen with the 
potential to induce tumors in diverse organs especially 
in the liver. DEN is extensively reported to be found in 
processed meats, tobacco products, cheese, soybean, 
cosmetics, drinking water, alcoholic beverages, and a 
variety of workplaces [‎6-8]. It has been widely used as a 
carcinogen in cancer investigation to induce HCC or 
different kinds of benign and malignant tumors in 
experimental animal models. It is strongly believed that 
DEN is metabolized in the liver by cytochrome P450 
enzymes and is transformed to a reactive metabolite. 
Eventually, these active free radicals attack DNA and 
produce oxidative damages,which result in the 
formation of HCC [‎9]. 
Presently, there are no proven effective chemotherapeutic 
or surgical intervention for HCC and main focus is on 
cancer prevention strategies as a suitable method for 
controlling this aggressive cancer. Natural products 
have progressively become attractive agents in cancer 
prevention and treatment [‎10]. 
Melissa officinalis L., commonly called lemon balm is a 
medicinal herb of Lamiaceae, which has been 
traditionally used for the management of different 
diseases and as a food additive since about 2000 years 
ago [‎11]. 
 Pharmacological studies show that this valuable plant 
has many biological activities such as: antioxidant, anti-
inflammatory, antiviral, antibacterial, hypoglycemic, 
hypolipidemic, antidepressant, antianxiety, and 
neuroprotective effects [‎12-18]. In addition, M. 
officinalis possesses hepatoprective effect and 
significantly attenuates hepatotoxicity in hyperlipidemic 
rats [‎19]. Lemon balm was used in Iranian traditional 
medicine for the treatment of different types of cancer 
and there are several reports on the cytotoxic activity of 
the plant and its components in different cancer cell 
lines [‎11, ‎20-22]. Also, recent studies have pointed out 
the antigenotoxic and antiangiogenic activities of lemon 
balm [‎23, ‎24]. Therefore, this valuable plant could be 
efficacious in cancer prevention and treatment, 
however, the chemopreventive effect of M. officinalis 
have not yet been studied. Thus, the present 
investigation is aimed to evaluate the preventive activity 
of aqueous extract of M. officinalis (AMO) against 
DEN-induced HCC in rats. 
2. Materials & Methods 
2.1. Chemicals 
All chemicals were purchased from Sigma- Aldrich Co. 
(Taufkrichen, Germany) with the highest commercial 
grade available. 
2.2. Plant and extract preparation 
The aerial parts of M. officinalis obtained from local 
medicinal herb shops, Tehran, Iran, and were 
authenticate by Mr. Mohammad Kamalinejad, a 
qualified botanist at the Department of Botany, Shahid 
Beheshti University of Medical Sciences (8003, voucher 
specimen in Shahid Beheshti University of Medical 
Sciences Herbarium, Tehran, Iran). The plant was 
cleaned and the extraction was carried out by the 
maceration of 100 g plant with 900 mL distilled water 
for 30 min. The resulting extract was evaporated by 
placing in water bath 90°C. Finally, the extract was 
filtered and was kept at –20°C until use. The extract was 
dissolved in distilled water to receive desired 
concentrations just before use. The moisture level of the 
extract was determined by weight loss after placing 2 g 
of the final extract in an oven at 60–65°C for 72 h. The 
final extract contained 24% water [‎25]. 
2. 3. Standardization of Extract 
Total polyphenol content was determined by 
spectrophotometry, using gallic acid as the standard 
based on the Folin–Ciocalteu method [‎26]. Total 
phenolic content was 64.89 ± 2.33 mg gallic acid 
equivalents (GAE) per gram of AMO (mg of GAE/g of 
plant extract). Total flavonoid content was measured 
with the aluminum chloride colorimetric assay [‎27]. 
Quercetin was used as the standard and flavonoid 
contents were expressed as mg of quercetin equivalent 
per gram of AMO. Flavonoid contents were 36.25 ± 
1.17mg quercetin equivalents (QE) per gram of AMO 
(mg of QE /g of plant extract). 
2. 4. Animals 
Male Sprague-Dawley rats weighing 180 to 200 g were 
housed in ventilated plastic cages over PWI 8-16 
hardwood bedding. There were 12 air changes per hour, 
12 h light photoperiods, an environmental temperature 
of 21–23°C, and a relative humidity of 50–60%. The 
animals were fed a standard normal chow diet and given 
tap water ad libitum. Principles of laboratory animal 
care (NIH publication No. 85-23, revised 1985) were 
followed.  
2. 5. Hepatocarcinogenesis model 
The experimental model of HCC was induced in rats by 
DEN as the initiator and 2-acetylaminofluorene (2-
AAF) as the promoter of hepatocarcinogenesis 
according to the protocol described previously [‎28]. 
Briefly, rats were fasted for 96 h and then were refed for 
24 h as a proliferative stimulant. Afterward, rats were 
injected only a single intraperitoneal (i.p.) dose of DEN 
(200 mg/kg body weight) for initiating 
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hepatocarcinogenesis. After two weeks, liver cancer 
development was promoted with daily dose of oral 2-
AAF (30 mg/kg body weight) for two weeks. HCC was 
confirmed by histopathological evaluations and the 
measurement of liver damage and cancer markers, 
including alfa-fetoprotein (AFP), gamma glutamyl 
transpeptidase (GGT), alanine transaminase (ALT), and 
aspartate transaminase (AST) [‎29]. 
2. 6. Experimental design 
As shown in Fig. 1, rats were randomly divided into six 
different groups of six rats each (n = 6). Group 1 
(Control) animals were fed standard diet and served as a 
normal control, and were injected with the single dose 
of saline. Group 2 was normal animals that were treated 
only with daily oral dose of AMO (400 mg/kg body 
weight) from the beginning of the experiment. Group 3 
(HCC) rats served as untreated HCC animals as 
described before. Test group animals (Groups 4- 6) 
were pretreated with the increasing doses of AMO (100, 
200, and 400 mg/kg body weight, respectively) two weeks 
prior to DEN injection that continued until the end of the 
study. The different concentrations of the extract were 
selected based on previous studies and were administered 
orally once daily using an intragastric tube for 8 weeks 
[‎30]. 
 
Figure 1. Experimental design. i.p.: intraperitoneal. 
2. 7. Sample preparation 
At the end of the experiment, animals were 
anaesthetized by ether inhalation and blood samples 
were collected from the orbital sinus and centrifuged at 
1500×g for 20 minutes at 4°C to obtain serum for 
biochemical analysis. In addition, body weights of the 
animals were recorded and rats were sacrificed. Then, 
the liver tissues were quickly collected, weighed, and 
frozen for the determination of hepatic oxidative stress 
markers. Frozen liver samples were homogenized in ice-
cold Tris- HCL buffer (150 mM, pH 7.4). The relative 
liver weight was calculated as the percentage ratio of 
liver weight to the body weight. 
2. 8. Evaluation of biochemical parameters 
AFP level is widely used clinically as a tumor marker for 
HCC and is measured by Calbiotech AFP ELISA Kit 
[‎31]. The activities of biochemical markers of liver 
damage, including GGT, ALT, and AST were 
determined by commercially available enzyme kits 
(Pars Azmoon, Tehran, Iran) [‎32]. The assays were 
performed according to the protocols supplied with the 
kits. 
2. 9. Determination of protein concentration 
The concentration of liver protein was measured by the 
Coomassie blue protein-binding method using BSA as 
the standard [‎33]. 
2. 10.  Determination of hepatic oxidative stress 
markers 
Hepatic GSH contents were estimated in liver 
homogenate by a spectrophotometric method using 
dithiobis-2-nitrobenzoic acid (DTNB) as the indicator of 
GSH and expressed as µg/mg protein. The intensity of 
the yellow color produced in the samples was recorded 
at 412 nm with a UV spectrophotometer (Infinite M200, 
TECAN) [‎34]. 
The level of malondialdehyde (MDA) as a reliable  
marker of lipid peroxidation was estimated in liver 
homogenate by reading the absorbance of the 
supernatant layer at 532 nm with an ELISA reader 
instrument (Infinite M200, TECAN). MDA levels were 
presented as μg/mg protein [‎35]. 
2. 11. Statistical analysis 
The homogeneity of variances was tested using 
Levene’s test. The results were analyzed using one-way 
analysis of variance (ANOVA) followed by Tukey’s 
HSD as the post hoc test. The data were presented as the 
mean±SD (n=6). The results with level of significance 
(P<0.05) were regarded as significant. 
3. Results 
3.1. Effects of AMO on serum biochemical  
parameters 
Serum AFP is one of the most frequent diagnostic 
markers for HCC, which was significantly enhanced in 
this investigation in HCC rats compared to normal rats  
(P < 0.001). As can be seen in Fig. 2, the oral 
pretreatment of different concentrations of AMO to HCC 
rats caused a significant reduction in AFP. In addition, 
our results showed that the activities of GGT, ALT, and 
AST were clearly increased in DEN-treated rats 
compared to normal animals at the end of the experiment 
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(Fig. 3-5). The elevations in the serum markers of liver 
injury, including GGT, ALT, and AST were effectively 
decreased in AMO-treated rats. Besides, it was shown 
that the treatment of normal rats (Group 2) with AMO 
(400 mg/kg body weight daily) did not alter the 
biochemical markers (Fig. 2-5). 
 
 
Figure 2. Effects of the lemon balm extract (AMO) on AFP. Values 
are presented as mean±SD. *** P<0.001 compared to normal group; 
ФФ P<0.01, ФФФ P<0.001 compared to HCC rats. 
 
 
Figure 3. Effects of the lemon balm extract (AMO) on) GGT. Values 
are presented as mean±SD. *** P<0.001 compared to normal group; Ф 
P<0.05, ФФ P<0.01, ФФФ P<0.001 compared to HCC rats. 
 
 
Figure 4. Effects of the lemon balm extract (AMO) on ALT. Values 
are presented as mean±SD. *** P<0.001 compared to normal group; Ф 
P<0.05, ФФ P<0.01, ФФФ P<0.001 compared to HCC rats. 
 
Figure 5. Effects of the lemon balm extract (AMO) on AST. Values 
are presented as mean±SD. *** P<0.001 compared to normal group; 
ФФ P<0.01, ФФФ P<0.001 compared to HCC rats. 
3.2. Effects of AMO on the hepatic markers of 
oxidative stress 
GSH and its related antioxidant defense system are 
required to neutralize free radicals such as electrophilic 
carcinogens and to counteract oxidative stress. As 
indicated in Fig. 6, hepatic GSH levels were decreased in 
DEN-treated rats compared with normal rats (P < 0.001). 
Moreover, MDA levels as one of the important markers 
of oxidative stress were increased in HCC rats 
compared to normal animals (P < 0.001) (Fig. 7). In this 
study, the pretreatment with the lemon balm extract to 
HCC rats caused an elevation in GSH concentrations 
along with a reduction in lipid peroxidation (Figs. 6 and 
7). It can be also seen that the oral administration of 
AMO (400 mg/kg body weight/daily) in normal rats did 
not change the oxidative stress markers (Figs. 6 and 7). 
 
Figure 6. Effects of the lemon balm extract (AMO) on hepatic 
GSH contents. Values are presented as mean±SD. *** P<0.001 




Figure 7. Effects of the lemon balm extract (AMO) on liver lipid 
peroxidation. MDA formation as the marker of lipid peroxidation 
was expressed as µg/mg protein. Values are presented as mean±SD. 
*** P<0.001 compared to normal group; Ф P<0.05, ФФФ P<0.001 
compared to HCC rats. 
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Figure 8. Effects of the lemon balm extract (AMO) on relative 
liver weight. Values are presented as mean±SD. ** P<0.01 compared 
to normal group; Ф P<0.05 compared to HCC rats. 
3.3. Effect of AMO on relative liver weight 
As presented in Fig. 8, the relative liver weight of HCC 
rats was improved as compared to the normal animals 
(P < 0.01). Our results indicated that the oral 
administration of AMO to DEN-treated rats caused a 
significant decrease in relative liver weight (P < 0.01). 
Again, the pretreatment of normal rats (Group 2) with 
AMO (400 mg/kg body weight daily) did not affect the 
relative liver weight (Fig. 8). 
 
4. Discussion and Conclusion 
The incidence and mortality of primary liver cancer or 
HCC are rising throughout the world and unfortunately, 
it is often diagnosed at advanced stages. In the absence 
of proven effective chemotherapy and surgical 
intervention for HCC treatment, chemoprevention is 
needed for decreasing the risk or delaying the onset of 
this progressive cancer especially in high-risk 
individuals. Recently, more attention has been focused 
on medicinal herbs and phytochemicals as an effective 
chemopreventive agents because of their preventive 
activity against common cancers like HCC [‎28]. 
M. officinalis commonly known as lemon balm is 
considered as a potential agent for cancer prevention 
and treatment because of its cytotoxic and 
antiproliferative effects in different tumor cell lines [‎20-
22]. Also, it has been reported that lemon balm 
presented apoptosis-inducing activity as well as 
antigenotoxic, and antimutagenic effects in different in 
vitro and in vivo models [‎24, ‎36]. In the present study, 
we investigated the chemopreventive effect of M. 
officinalis against DEN-induced HCC in rats at the end 
stage of hepatotoxicity. Our results clearly demonstrated 
that lemon balm possesses a predominant 
chemopreventive activity in the rat model of HCC 
which is evident from reduction in the serum markers of 
liver damage and cancer. 
Serum α-fetoprotein or AFP level is considered an 
important diagnostic marker for HCC [‎37]. Elevated 
AFP serum levels are only seen in certain tumors (e.g. 
HCC), non-tumoral conditions (e.g. cirrhosis), and 
maternal serum during pregnancy. As shown in Fig. 2, 
the increased concentration of AFP was effectively 
reduced by the lemon balm extract. In addition, GGT, 
ALT, and AST are the most widely used HCC tumor 
markers. GGT expression in tumor cells provides a 
selective advantage to the cells during tumor promotion 
and enables them to preserve elevated levels of 
intracellular GSH. Therefore, it has been suggested that 
GGT is an independent prognostic indicator in patients 
with HCC [‎38]. As shown in Fig. 2, the activities of 
GGT, ALT, and AST were excellently decreased by the 
lemon balm extract. 
Glutathione and glutathione-related enzymes play a 
pivotal role in the metabolism and detoxification of free 
radicals and carcinogenic compounds. They are also 
involved in the regulation of carcinogenic mechanisms 
and cancer cell death [‎39]. It has been reported that 
GSH levels and the activities of GSH-dependent 
enzymes in the liver tissue of HCC patients were 
diminished because of the deficiency of antioxidant 
defense system [‎40]. Our results clearly point out that 
the lemon balm extract counteracted DEN-induced 
oxidative stress and restored GSH concentrations in rat 
livers treated with lemon balm. 
Lipid peroxidation, as an important marker of oxidative 
stress, is a well-defined mechanism of cellular damage 
in different pathological conditions [‎41, ‎42]. MDA is 
the end product of lipid peroxidation that is involved in 
the promotion and progression stages of carcinogenesis 
[‎43, ‎44]. In this study, the oral administration of lemon 
balm to DEN-treated rats decreased MDA levels and 
liver lipid peroxidation. Finally, our results indicated 
that the extract prevented any increase in relative liver 
weight caused by DEN treatment. 
It is strongly believed that inflammation-mediated 
processes and oxidative stress contribute to the 
development and progression of hepatocarcinogenesis 
through different mechanisms [‎45]. Regarding the 
antioxidant and anti-inflammatory as well as 
hepatoprotective and anti-cancer activities of lemon 
balm, it can be suggested that these biological activities 
are responsible for the chemopreventive of the plant. 
Recently, there has been a great interest in natural 
polyphenols potentially used as chemopreventive 
agents. Many in vitro and in vivo studies have suggested 
that these natural compounds are promising candidates 
for HCC prevention by reversing, suppressing or 
preventing the different steps of hepatocarcinogenesis 
through various mechanisms [‎46]. The different kinds of 
phenolic compounds, including phenolic acids, 
flavonoids, and tannins have been found in M. 
officinalis in addition to many different valuable 
compounds [‎11, ‎47-‎48]. Phenolic acids such as gallic 
acid are the main components of the plant, which has 
been also reported that have many beneficial effects 
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from the anti-cancer point of view [‎49]. In the present 
study, more than 6% of the total weight of the extract 
related to polyphenolic compounds. So, it can be 
suggested that the preventive activity of lemon balm 
against HCC may be mediated through the antioxidant, 
anti-inflammation, and anti-carcinogenic effects of 
polyphenols. However, further studies to elucidate 
underlying mechanisms of the effect would be 
complementary to this study. In addition, the authors 
believe that additional experiments are necessary to 
explain which active constituents are responsible for the 
chemopreventive effect of lemon balm against liver 
cancer and to detect synergy among different 
compounds of this valuable fruit. 
For conclusion, our findings obviously showed that M. 
officinalis has a preventive effect against DEN-induced 
liver cancer by decreasing serum biomarkers of liver 
damage and cancer. Besides, M. officinalis displayed in 
vivo antioxidant activity by elevating GSH contents in 
addition to prevent lipid peroxidation in the liver tissues 
of HCC rats. The relative weight of liver was similarly 
diminished in the extract-treaded rats. 
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